The safety and efficacy of Celgene's CAR T cell therapies are under investigation and have not been established. There is no guarantee that these agents will receive health authority approval or become commercially available in any country for the uses being investigated.

Cancer Immune Response

Refresh your knowledge about the immune response to cancer, and how cancer can evade detection

CAR T Science

Learn about the science behind CAR T cell therapies

B Cell Malignancies

Learn about unmet needs in select B cell malignancies

CAR T Process

Learn what the CAR T therapy process may involve for you and your patients

CAR T Cell Therapy

Autologous cellular biologics under investigation as adoptive immunotherapy for certain B cell malignancies.1
×

Reference:

  1. Park JH, Brentjens RJ. Discov Med. 2010;9:277-288.

This website is intended for US healthcare professionals only. Are you a US healthcare professional?

NO
YES